Mutations, drugs drive cancer by blurring growth signals.
Mutations, drugs drive cancer by blurring growth signals Researchers control common cancer pathway in lab with pulses of light Date: August 31, 2018 Source: University of California - San Francisco Summary: Genetic mutations in a form of non-small cell lung cancer (NSCLC) may drive tumor formation by blurring cells' perception of key growth signals, according to a new laboratory study. The research could have important implications for understanding and ultimately targeting the defective mechanisms underlying many human cancers. Share: FULL STORY Genetic mutations in a form of non-small cell lung cancer (NSCLC) may drive tumor formation by blurring cells' perception of key growth signals, according to a new laboratory study published August 31, 2018 in Science . The research, led by UC San Francisco researchers, could have important implications for understanding and ultimately targeting the defective mechanisms underly...